Lopimune Tablet is a combination medication primarily used in the management of HIV infection. Each tablet contains two active ingredients: Ritonavir (50 mg) and Lopinavir (200 mg). Ritonavir is a protease inhibitor that enhances the effectiveness of Lopinavir, another protease inhibitor, by increasing its bioavailability. Together, these components work synergistically to inhibit the replication of the HIV virus, thereby helping to control the infection and improve the immune system’s function. Lopimune is typically prescribed as part of a comprehensive antiretroviral therapy regimen, which may include other medications to ensure a robust response against HIV. The tablet is designed for oral administration and is often taken in conjunction with food to enhance absorption. This medication is crucial for individuals living with HIV, as it helps to reduce viral load, improve quality of life, and prevent the progression to AIDS.